AB0315 High Disease Activity at Baseline, Not Rf Nor Acpa Status, Predicts Inadequate Response to Methotrexate (MTX) in Patients With Early Rheumatoid Arthritis in Real World: A Single Centrecohort in Japan
doi 10.1136/annrheumdis-2018-eular.2666
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism